Exploring the Early Stages of the Biotech Chips Act and Potential Geopolitical Impact

After whisking through Washington for the first half of the year, raising alarms, mutating and causing confusion, the Biosecure Act is now on pause. On the latest BioCentury This Week podcast, BioCentury’s editors discuss what the delay for the legislation, which seeks to drive Chinese contract development and manufacturing organizations out of the U.S., means, what will happen next, and how it will impact life sciences companies.

View full story: https://www.biocentury.com/article/652771

03:09 - What's In, What's Out
05:41 - Broader Impact
11:07 - Wake-up Call

Reach us by sending a text